Article

Module brings next-generation OCT technology

Heidelberg Engineering announces significant improvements to its Spectralis OCT2 Module.

Heidelberg Engineering announces significant improvements to its Spectralis OCT2 Module.  

The module brings next-generation optical coherence tomography (OCT) technology to the diagnostic imaging platform. It combines a high-scan rate with Heidelberg Engineering’s TruTrack Active Eye Tracking to provide unmatched image quality and significantly improved acquisition speed, according to the company

New applications, such as OCT angiography, will build on the module.

The module is an option for all new Spectralis models. In addition, a large number of devices in use-depending on their technical specifications-can be upgraded with the module.

Introduced with a high-scan rate of 70,000 Hz, Heidelberg Engineering was able to achieve another significant improvement in the acquisition speed, said the company in a prepared statement.

“[The] team in Heidelberg was able to increase the scan rate of the [module] from 70,000 Hz to 85,000 Hz,” said Kester Nahen, PhD, managing director at Heidelberg Engineering. “This is an important achievement and further substantiates the sound technology pathway we have defined. I’m confident that our customers will be delighted with this even more powerful engine.”

 

 

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Abby Markward, MBA, and Hattie Hayes, editor of Ophthalmology Times Europe, discuss the ASCRS and ASOA meetings
Abby Markward discusses the ASCRS Foundation and the ASCRS Annual Meeting
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
(Image credit: Ophthalmology Times) NeuroOp Guru: Cranial nerve six palsy with chemosis is a critical clue to cavernous carotid fistula
(Image credit: Ophthalmology Times) Neda Shamie_Controversies in Modern Eye Care 2025
© 2025 MJH Life Sciences

All rights reserved.